These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7704941)

  • 1. Increased angiotensin-converting enzyme activity in cerebrospinal fluid of treated patients with Parkinson's disease.
    Konings CH; Kuiper MA; Bergmans PL; Grijpma AM; van Kamp GJ; Wolters EC
    Clin Chim Acta; 1994 Nov; 231(1):101-6. PubMed ID: 7704941
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy.
    Zubenko GS; Volicer L; Direnfeld LK; Freeman M; Langlais PJ; Nixon RA
    Brain Res; 1985 Mar; 328(2):215-21. PubMed ID: 2985183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-evaluation of cerebrospinal fluid angiotensin-converting enzyme activity in patients with 'probable' Alzheimer's disease.
    Konings CH; Kuiper MA; Scheltens P; Grijpma AM; van Pelt W; Wolters EC
    Eur J Clin Chem Clin Biochem; 1993 Aug; 31(8):495-7. PubMed ID: 8218581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low angiotensin-converting enzyme activity (kininase II) in cerebrospinal fluid of schizophrenics.
    Beckmann H; Saavedra JM; Gattaz WF
    Biol Psychiatry; 1984 May; 19(5):679-84. PubMed ID: 6145452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme activity in cerebrospinal fluid (CSF).
    Briddon A
    Clin Chem; 1992 Mar; 38(3):439. PubMed ID: 1312400
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin converting enzyme in the Parkinsonian brain.
    Rinne UK; Koskinen V; Laaksonen H; Tenovuo O
    Ann Neurol; 1978 Nov; 4(5):483. PubMed ID: 216304
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebrospinal fluid angiotensin converting enzyme levels in the diagnosis of neurosarcoidosis.
    Jones DB; Mitchell D; Horn DB; Edwards CR
    Scott Med J; 1991 Oct; 36(5):144-5. PubMed ID: 1664971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis.
    Kawajiri M; Mogi M; Higaki N; Matsuoka T; Ohyagi Y; Tsukuda K; Kohara K; Horiuchi M; Miki T; Kira JI
    Mult Scler; 2009 Feb; 15(2):262-5. PubMed ID: 19136547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher cerebrospinal fluid angiotensin-converting enzyme levels in neuroleptic-treated than in drug-free patients with schizophrenia.
    Wahlbeck K; Ahokas A; Miettinen K; Nikkilä H; Rimón R
    Schizophr Bull; 1998; 24(3):391-7. PubMed ID: 9718631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis.
    Dale JC; O'Brien JF
    Mayo Clin Proc; 1999 May; 74(5):535. PubMed ID: 10319092
    [No Abstract]   [Full Text] [Related]  

  • 11. Elevated plasma vasopressin and normal cerebrospinal fluid angiotensin-converting enzyme in chronic pain disorder.
    Wahlbeck K; Sundblom M; Kalso E; Tigerstedt I; Rimón R
    Biol Psychiatry; 1996 Nov; 40(10):994-9. PubMed ID: 8915558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiotensin-converting enzyme (ACE) I/D polymorphism in Parkinson's disease.
    Su G; Dou H; Zhao L; Wang H; Liu G; Huang B; Peng B
    J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):428-33. PubMed ID: 23833036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme in cerebrospinal fluid: a new assay.
    Oksanen V; Fyhrquist F; Somer H; Grönhagen-Riska C
    Neurology; 1985 Aug; 35(8):1220-3. PubMed ID: 2991815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular heterogeneity of angiotensin converting enzyme in human cerebrospinal fluid.
    Lantz I; Nyberg F; Terenius L
    Biochem Int; 1991 Mar; 23(5):941-8. PubMed ID: 1715707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease.
    Lin JJ; Yueh KC; Lin SZ; Harn HJ; Liu JT
    J Neurol Sci; 2007 Jan; 252(2):130-4. PubMed ID: 17196621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insertion/deletion polymorphism in the angiotensin-converting enzyme and susceptibility to schizophrenia or Parkinson's disease: A meta-analysis.
    Song GG; Lee YH
    J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):434-42. PubMed ID: 25143327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF angiotensin II and angiotensin-converting enzyme levels in anti-aquaporin-4 autoimmunity.
    Matsushita T; Isobe N; Kawajiri M; Mogi M; Tsukuda K; Horiuchi M; Ohyagi Y; Kira J
    J Neurol Sci; 2010 Aug; 295(1-2):41-5. PubMed ID: 20541774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of Angiotensin-Converting Enzyme is not associated with the development of Parkinson's disease and of L-dopa-induced adverse effects.
    Pascale E; Purcaro C; Passarelli E; Guglielmi R; Vestri AR; Passarelli F; Meco G
    J Neurol Sci; 2009 Jan; 276(1-2):18-21. PubMed ID: 18805557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the Enzymatic Activity of Angiotensin-Converting Enzyme 2 (ACE2) in Brain Tissue and Cerebrospinal Fluid Using a Quenched Fluorescent Substrate.
    Sriramula S; Pedersen KB; Xia H; Lazartigues E
    Methods Mol Biol; 2017; 1527():117-126. PubMed ID: 28116711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis.
    Bridel C; Courvoisier DS; Vuilleumier N; Lalive PH
    J Neuroimmunol; 2015 Aug; 285():1-3. PubMed ID: 26198911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.